Pablo Forte

1.0k total citations
25 papers, 827 citations indexed

About

Pablo Forte is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pablo Forte has authored 25 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pablo Forte's work include Nitric Oxide and Endothelin Effects (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Pablo Forte is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Pablo Forte collaborates with scholars based in United Kingdom, Sweden and Venezuela. Pablo Forte's co-authors include Nigel Benjamin, E. Milne, Lorna Smith, Mhairi Copland, John C. Sutherland, A. E. Johnston, Phil Chowienczyk, James M. Ritter, Barry J. Kneale and Alexandra Jauhiainen and has published in prestigious journals such as The Lancet, Diabetes and Gut.

In The Last Decade

Pablo Forte

25 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Forte United Kingdom	12	385	316	179	133	91	25	827
Jonathan Blau United States	10	289 0.8×	333 1.1×	174 1.0×	239 1.8×	175 1.9×	21	1.1k
Nicole Lüneburg Germany	21	394 1.0×	407 1.3×	71 0.4×	220 1.7×	182 2.0×	38	1.0k
Ali A. Khraibi United States	18	264 0.7×	255 0.8×	133 0.7×	110 0.8×	218 2.4×	51	859
Roberto S. Cunha Brazil	16	204 0.5×	678 2.1×	197 1.1×	92 0.7×	129 1.4×	24	1.1k
Paul Modlinger United States	8	251 0.7×	211 0.7×	86 0.5×	57 0.4×	135 1.5×	9	653
Steffen Daub Germany	14	282 0.7×	199 0.6×	178 1.0×	85 0.6×	255 2.8×	21	953
G. Noll Switzerland	20	501 1.3×	635 2.0×	179 1.0×	85 0.6×	230 2.5×	49	1.4k
Fabrizio Ceci Italy	24	324 0.8×	326 1.0×	433 2.4×	103 0.8×	216 2.4×	54	1.4k
Anna Ollerstam Sweden	14	273 0.7×	279 0.9×	71 0.4×	124 0.9×	359 3.9×	25	832
Camila Manrique‐Acevedo United States	17	234 0.6×	362 1.1×	346 1.9×	92 0.7×	228 2.5×	61	1.1k

Countries citing papers authored by Pablo Forte

Since Specialization

Citations

This map shows the geographic impact of Pablo Forte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Forte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Forte more than expected).

Fields of papers citing papers by Pablo Forte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Forte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Forte. The network helps show where Pablo Forte may publish in the future.

Co-authorship network of co-authors of Pablo Forte

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Forte. A scholar is included among the top collaborators of Pablo Forte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Forte. Pablo Forte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Forte, Pablo, et al.. (2023). Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects. Clinical Pharmacokinetics. 62(4). 635–644. 11 indexed citations

Moorthy, Ganesh, Gayle P. Pouliot, Lorraine Graham, et al.. (2023). Comprehensive clinical pharmacology characterization of AZD4635 in healthy participants to support dosing considerations. British Journal of Clinical Pharmacology. 89(9). 2775–2787. 3 indexed citations

Forte, Pablo, et al.. (2021). Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin‐Releasing Hormone Antagonist, in Healthy Adult Subjects. Clinical Pharmacology in Drug Development. 11(2). 257–269. 7 indexed citations

Whittaker, Andrew K., Muna Albayaty, Peter J. Greasley, et al.. (2019). Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study. Clinical and Translational Science. 13(2). 275–283. 24 indexed citations

Gillen, Michael, et al.. (2018). Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort® (budesonide/formoterol) pressurized metered dose inhaler. Pulmonary Pharmacology & Therapeutics. 52. 7–17. 11 indexed citations

Palmer, Robert S., Jukka Mäenpää, Alexandra Jauhiainen, et al.. (2018). Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects. Clinical Pharmacology & Therapeutics. 104(6). 1155–1164. 76 indexed citations

Forte, Pablo, et al.. (2006). A Noninvasive, Sensitive, Specific, and Reliable Approach to Assess Whole-Body Nitric Oxide Synthesis in Children. Pediatric Research. 59(5). 736–741. 4 indexed citations

Zacharowski, K., Claire Donnellan, A. E. Johnston, et al.. (2004). The effects and metabolic fate of nitroflurbiprofen in healthy volunteers. Clinical Pharmacology & Therapeutics. 76(4). 350–358. 12 indexed citations

Forte, Pablo, L.Jackson Roberts, Jason D. Morrow, et al.. (2000). Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion.. Diabetes. 49(5). 857–862. 46 indexed citations

10.

Forte, Pablo, R S Dykhuizen, E. Milne, et al.. (1999). Nitric oxide synthesis in patients with infective gastroenteritis. Gut. 45(3). 355–361. 26 indexed citations

11.

Forte, Pablo, Lorna Smith, E. Milne, & Nigel Benjamin. (1999). [10] Measurement of nitric oxide synthesis in humans using l-[15N2]arginine. Methods in enzymology on CD-ROM/Methods in enzymology. 301. 92–98. 8 indexed citations

12.

Forte, Pablo, Barry J. Kneale, E. Milne, et al.. (1998). Evidence for a Difference in Nitric Oxide Biosynthesis Between Healthy Women and Men. Hypertension. 32(4). 730–734. 201 indexed citations

13.

Forte, Pablo, Mhairi Copland, Lorna Smith, et al.. (1997). Basal nitric oxide synthesis in essential hypertension. The Lancet. 349(9055). 837–842. 308 indexed citations

14.

Forte, Pablo, et al.. (1995). DOPAMINERGIC INFLUENCE ON THE CARDIOVASCULAR AND HORMONAL RESPONSES TO COLD STRESS IN HYPERTENSIVE PATIENTS. American Journal of Therapeutics. 2(3). 175–179. 1 indexed citations

15.

Grilli, Massimo, et al.. (1995). Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.. PubMed. 33(9). 509–12. 8 indexed citations

16.

Baggio, Giovannella, et al.. (1994). Efficacy and Safety of Fluvastatin, a New HMG CoA Reductase Inhibitor, in Elderly Hypercholesterolaemic Women. Drugs. 47(Supplement 2). 59–63. 11 indexed citations

17.

Martin, Gladys, et al.. (1994). Dopamine‐Induced Antihypertensive Effects and Plasma Insulin Rise Are Blocked by Metoclopramide in Labetalol‐Treated Patients. The Journal of Clinical Pharmacology. 34(1). 91–94. 7 indexed citations

18.

Baggio, Giovannella, et al.. (1994). Efficacy and safety of fluvastatin in elderly hypercholesterolemic patients: A pilot study. Current Therapeutic Research. 55(4). 401–407. 1 indexed citations

19.

Martin, Gladys, et al.. (1993). Effect of intravenous dopamine on blood pressure and plasma insulin in hypertensive patients. European Journal of Clinical Pharmacology. 45(6). 503–505. 10 indexed citations

20.

Forte, Pablo, et al.. (1993). Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.. PubMed. 31(8). 404–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact